Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Repligen Corp (RGEN) until September 8, 2023. Repligen Corp reported in an 8-K filed September 12, 2023 that Jon Snodgres retired as CFO. Repligen Corp reported in an 8-K filed September 12, 2023 that Jon Snodgres retired as Chief Financial Officer, effective September 8, 2023. The proxy statement of Repligen Corp reports total compensation of $2,170,932 for Jon Snodgres in fiscal 2023, including a base salary of $409,997. Disclosed compensation is on record for 7 fiscal years. Jon Snodgres has spoken on 14 earnings calls across 1 company, most recently for Repligen Corp on August 2, 2023. The companies whose calls Jon Snodgres spoke on are classified in the Healthcare sector.
“He succeeds retiring CFO Jon K. Snodgres, who joined the Company in June 2014 and will continue in a full-time advisory role until October 6, working closely with Mr. Garland to ensure a smooth transition.”
“On September 12, 2023, Repligen Corporation (the “Company”) announced that Jason K. Garland would be joining the Company as its Chief Financial Officer, effective September 25, 2023 (the “Effective Date”), replacing Jon Snodgres, who tendered his intention to retire on September 8, 2023 and who will continue in a full-time advisory role with the Company until October 6, 2023.”
“Today, we are reporting our financial results for the second quarter of 2023 as well as updating our financial guidance for the year. Unless otherwise mentioned, all financial measures discussed reflect adjusted non-GAAP measures.”
“Today, we are reporting our financial results for the first quarter of 2023, as well as updating our financial guidance for the year. Unless otherwise mentioned, all financial measures discussed reflect adjusted non-GAAP measures.”
“Today, we are reporting our financial results for the fourth quarter of 2022 as well as providing our financial guidance for the year 2023. Unless otherwise mentioned, all financial measures discussed reflect adjusted non-GAAP measures.”
“Today, we are reporting our financial results for the third quarter as well as updating our financial guidance for the year. Unless otherwise mentioned, all financial measures discussed reflect adjusted non-GAAP measures.”
“Today, we are reporting our financial results for the second quarter, as well as updating our financial guidance for the year. Unless otherwise mentioned, all financial measures discussed reflect adjusted non-GAAP measures.”
Start not stated–2023-09-08
RGEN
Medical Instruments & Supplies · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Repligen Corp (RGEN) | Former Chief Financial Officer | $409,997 | $2,170,932 |
| 2022 | Repligen Corp (RGEN) | Former Chief Financial Officer | $465,426 | $2,426,541 |
| 2021 | Repligen Corp (RGEN) | Former Chief Financial Officer | $432,954 | $2,372,231 |
| 2020 | Repligen Corp (RGEN) | Chief Financial Officer | $393,594 | $1,991,629 |
| 2019 | Repligen Corp (RGEN) | Chief Financial Officer | $371,315 | $1,876,607 |
| 2018 | Repligen Corp (RGEN) | Chief Financial Officer | $360,500 | $1,307,443 |
| 2017 | Repligen Corp (RGEN) | Chief Financial Officer | $350,097 | $1,250,852 |
